Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.78B |
| 2 |
Microsoft
MSFT
|
+$2.22B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.67B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.65B |
| 5 |
State Street Materials Select Sector SPDR ETF
XLB
|
+$1.19B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.45B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$533M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$410M |
| 4 |
Stellantis
STLA
|
+$312M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.28% |
| 2 | Healthcare | 11.27% |
| 3 | Financials | 10.52% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 7.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Green Dot
GDOT
$748M
| $482K | ﹤0.01% |
25,729
+1,452
| +6% | +$25.7K |
|
2677
Fulcrum Therapeutics
FULC
$290M
| $478K | ﹤0.01% |
144,983
+117,730
| +432% | +$346K |
|
2678
Mercantile Bank Corp
MBWM
$1.07B
| $476K | ﹤0.01% |
17,246
+2,327
| +16% | +$64.5K |
|
2679
Nabors Industries
NBR
$1.24B
| $476K | ﹤0.01% |
5,117
-1,371
| -21% | -$139K |
|
2680
Treace Medical Concepts
TMCI
$307M
| $475K | ﹤0.01% |
19,274
+653
| +4% | +$16.9K |
|
2681
Consensus Cloud Solutions
CCSI
$708M
| $475K | ﹤0.01% |
15,334
+4,329
| +39% | +$152K |
|
2682
Southern Missouri Bancorp
SMBC
$874M
| $474K | ﹤0.01% |
12,325
-457
| -4% | -$16.8K |
|
|
SILK
2683
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $474K | ﹤0.01% |
14,584
-4,417
| -23% | -$161K |
|
2684
AtaiBeckley Inc
ATAI
$2.66B
| $473K | ﹤0.01% |
275,131
+22,414
| +9% | +$41.3K |
|
2685
US Global Jets ETF
JETS
$822M
| $472K | ﹤0.01% |
22,056
+22,026
| +73,420% | +$414K |
|
|
SCS
2686
DELISTED
Steelcase
SCS
| $471K | ﹤0.01% |
61,150
-3,164
| -5% | -$23.9K |
|
2687
Great Southern Bancorp
GSBC
$893M
| $471K | ﹤0.01% |
9,291
+2,632
| +40% | +$135K |
|
2688
Fulgent Genetics
FLGT
$527M
| $471K | ﹤0.01% |
12,720
-907
| -7% | -$31.6K |
|
|
BRY
2689
DELISTED
Berry Corp
BRY
| $471K | ﹤0.01% |
68,419
-11,919
| -15% | -$85.9K |
|
2690
UWM Holdings
UWMC
$661M
| $470K | ﹤0.01% |
83,933
+26,467
| +46% | +$143K |
|
2691
Sunoco
SUN
$14B
| $469K | ﹤0.01% |
10,759
| – | – |
|
2692
Insteel Industries
IIIN
$638M
| $468K | ﹤0.01% |
15,026
-864
| -5% | -$25.6K |
|
2693
Ingles Markets
IMKTA
$1.74B
| $467K | ﹤0.01% |
5,646
-1,975
| -26% | -$170K |
|
2694
Seaboard Corp
SEB
$4.21B
| $466K | ﹤0.01% |
131
+37
| +39% | +$141K |
|
|
SPWR
2695
DELISTED
SunPower Corporation Common Stock
SPWR
| $466K | ﹤0.01% |
47,572
-22,015
| -32% | -$257K |
|
2696
SFL Corp
SFL
$1.61B
| $465K | ﹤0.01% |
49,841
-46,044
| -48% | -$417K |
|
2697
NRC Health Common Stock
NRC
$434M
| $464K | ﹤0.01% |
10,659
-6,656
| -38% | -$293K |
|
|
GRP.U
2698
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $462K | ﹤0.01% |
7,830
-3,060
| -28% | -$185K |
|
2699
Sweetgreen
SG
$679M
| $462K | ﹤0.01% |
36,000
-10,035
| -22% | -$92.9K |
|
2700
Southern First Bancshares
SFST
$607M
| $461K | ﹤0.01% |
18,644
+183
| +1% | +$4.77K |
|
Similar funds
Barclays's Q2 2023 Portfolio in Review
As of Q2 2023, Barclays held 5,371 positions worth $158B, down 28% from $218B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Barclays withdrew a net $70.1B in Q2 2023, closing 872 positions and reducing 1,669 holdings. Its most notable exit was DCP Midstream, LP, an estimated $47.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR Nuveen ICE Municipal Bond ETF worth $36.9M.
- Barclays's largest Q2 2023 buy was State Street SPDR Nuveen ICE Municipal Bond ETF: 799,988 shares worth $36.9M.
- Barclays added most to Apple in Q2 2023, an estimated $2.78B increase.
- Barclays's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.45B.
- Barclays fully exited DCP Midstream, LP in Q2 2023, selling an estimated $47.3M.
- Barclays's ten largest holdings make up 24% of its $158B portfolio in Q2 2023.
- Barclays opened 314 new positions and closed 872 in Q2 2023.
- Barclays's portfolio value fell 28% quarter-over-quarter to $158B.
Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.